Last reviewed · How we verify
NCT03178825
Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause
NA trial testing Hybrid Fractional Laser in Vaginal Atrophy in 60 participants. Completed in 25 February 2020.
25 February 2020
Quick facts
| Lead sponsor | Sciton |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 19 May 2017 |
| Primary completion | 25 February 2020 |
| Estimated completion | 25 February 2020 |
| Sites | 6 locations across United States |
Drugs / interventions tested
- Hybrid Fractional Laser
Conditions studied
- Vaginal Atrophy — all drugs for Vaginal Atrophy →
- Sexual Dysfunction — all drugs for Sexual Dysfunction →
- Dyspareunia — all drugs for Dyspareunia →
- Vaginal Dryness — all drugs for Vaginal Dryness →
Sponsor
Sciton
Who can join
Adults 40 to 70, female only, with Vaginal Atrophy or Sexual Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This multi-center clinical trial will evaluate the safety and long-term efficacy of hybrid fractional 2940 nm and 1470 nm lasers for treatment of symptoms of Genitourinary Syndrome of Menopause.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03178825
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Hybrid Fractional Laser
Trials testing the same drug.
- NCT06436261 — Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With a Hybrid-Fractional · NA · completed
- NCT03969485 — Hybrid Fractional Laser for Treatment of Off Face Body Skin Quality · NA · completed
- NCT03647189 — Randomized, Controlled Trial With Hybrid Fractional Laser · NA · completed
- NCT03180372 — Hybrid Fractional Laser Treatment for Symptoms of Urinary Incontinence · NA · completed
Other recruiting trials for Vaginal Atrophy
Currently open trials in the same condition.
- NCT05457972 — Postpartum Vaginal Estrogen for Breastfeeding Patients · Phase 4 · recruiting
- NCT06028009 — PRP Injections for Genitourinary Syndrome of Menopause · NA · active not recruiting
- NCT07024667 — Clinical and Molecular Study to Evaluate the Effect of the Pixel CO2 Laser (FemiLiftTM) for the Treatment of Vulvo-Vagin · NA · recruiting
- NCT05335317 — Treatment of Vaginal Atrophy With Low Intensity Nanosecond Neodymium Laser · NA · recruiting
- NCT04807894 — Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo · Phase 4 · recruiting
Other Sciton trials
Trials by the same sponsor.
- NCT06363240 — Evaluation of Broadband Light Treatment for Solar Lentigines · NA · completed
- NCT06389071 — Laser Treatment for Lichen Sclerosus · NA · recruiting
- NCT05750901 — Evaluation of Fractional Ablative Laser Treatment for Skin Conditions · NA · recruiting
- NCT05662592 — Evaluation of Broadband Light Treatment Protocol for Pigmented Skin Lesions - A Comparative Study · NA · completed
- NCT05750914 — Evaluation of Broadband Light Treatment for Pigmented Skin Lesions · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03178825 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sciton
- Last refreshed: 11 August 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03178825.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing